RxDoctor Payments Data

Elizabeth Scheiber

Podiatrist · Boca Raton, FLNPI 1538123849

Payments from drug & device makers

$3,291in general payments, 2019–2025

Across 14 payments — averaging $235.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Endo Pharmaceuticals Inc.$3K
  • Abbott$152
  • Smith+Nephew$149
  • Paratek Pharmaceuticals, Inc.$125
  • Integra Lifesciences Corporation$110
  • Pacira Pharmaceuticals Incorporated$30
  • plus $110 from 5 others
$3,281in research payments, 2019–2025

Across 1 payment — averaging $3281.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Endo Pharmaceuticals Inc.$3K

What the payments were for

  • Consulting fees$2,53077%
  • Food & beverage$73822%
  • Education$231%

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,291 in reported general payments places this provider in the 70th percentile of 588 podiatrist providers in Florida.

See all podiatrist providers in Florida

Medicare billing

Part B allowed, 2024
$108,292
Medicare patients
611
Services billed
1,680

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CiclopiroxCiclopirox Olamine156$9,136
Ketoconazole113$3,119
Terbinafine Hcl71$504
Meloxicam31$60

Paid to pharmacies, not to this prescriber.

Other podiatrist in Boca Raton

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →